Transmyocardial laser revascularisation for refractory angina pectoris

significance and follow-up were not stated. 2.4.6 Specialist advisers stated that adverse events reported in the literature included death, myocardial infarction, heart failure, arrhythmias, and wound and other infections. 2.5 Other comments 2.5.1 The committee noted that some studies showed improvements in symptoms and quality of life, but considered that these were likely to be placebo responses in the light of evidence that showed no objective benefits. 2.5.2 The committee considered evidence on TMLR alone for refractory angina pectoris, and also on TMLR performed concomitantly with CABG. 3 Further information 3.1 NICE has published interventional procedures guidance on percutaneous laser revascularisation for refractory angina pectoris, technology appraisal guidance on myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction, and a guideline on managing stable angina.
